The US National Institutes of Health would get a 5% raise of $2bn under a 2020 budget increase to $41.1bn, spending that would go to boost precision medicine research, the BRAIN Initiative, Cancer Moonshot, cybersecurity and other important programs.
At a time when the Trump administration is calling for decreases in health-research spending, the US House wants to increase funding for the National Institutes of Health by $2bn over 2019 levels to bolster its precision medicine, ‘BRAIN’ initiative, and cybersecurity programs, among others.
The House Appropriations Committee delivered the good news for NIH supporters on 8 May by passing its 2020 Labor, Health and Human Services, and Education appropriations bill on a...
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
